Abbott Laboratories shares have climbed by over 4% on Thursday after it reported first-quarter earnings and revenue that bested Wall Street’s predictions, and is helping to boost ETFs that hold the healthcare company. Net sales climbed 2.5% to $7.73 billion, ahead of the average estimate of $7.34...